The Internet belongs to everyone. Let’s keep it that way.

Protect Net Neutrality
Loading presentation...

Present Remotely

Send the link below via email or IM

Copy

Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.

DeleteCancel

Researchfish Infographic for Researchers

No description
by

Cancer Research UK

on 26 June 2015

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of Researchfish Infographic for Researchers

PATENTS
45
10
SPIN-OUTS
699
12,000
1
ACTIVE CRUK
AWARDS
OUTPUTS
DATABASE
publications

CAMBRIDGE

30.3

ICR
23.9

DUNDEE
26.5

SHEFFIELD
22.3
22%
OF THESE
IN HIGH IMPACT JOURNALS
JIF BAND A AND B
So, what does the data collected through Researchfish tell us?
Let's take a closer look...
MEDALS
42
169
RESEARCH
PRIZES
PORTFOLIO
AN INSIGHT INTO THE CRUK

AN INSIGHT INTO CRUK
RESEARCHERS
We're proud to say that CRUK-funded researchers have been awarded...
And in 2014, papers were published in
37
We see that from all the outputs reported via Researchfish, CRUK Fellows report
25%
of all research tools,
methods, databases
& models
And
20%
of all engagement activities
We can also see evidence of
translation
COLLABORATIONS
WITH BIOTECH/PHARMA
+
+
And proof that
CRUK researchers
are
collaborating

around the world...

58%
18%
24%
UK
EUROPEAN
INTERNATIONAL
89
Researchfish can be used to demonstrate how CRUK-funded research is supporting our
strategic aims
7000
We know that CRUK researchers have published over
26.8

OXFORD
Researchfish allows us to evaluate outputs of funding on a variety of different levels
For example, if we're talking about...
CANCERS OF
UNMET NEED
5.3%
OF PUBLICATION TITLES
WE CAN SEE THESE APPEAR IN
LUNG
|
PANCREATIC
|
OESOPHAGEAL
|
BRAIN

(key word:
easily
)
What about CRUK
Fellows
– can Researchfish tell us anything about their outputs?
You know it!
Speaking of engagement, Researchfish also tells us that CRUK researchers engage with a
variety of audiences
oral presentations to a scientific/clinical audience
Activities include
294
With over
HALF
of these reaching
an international audience!
AN INSIGHT INTO CRUK
IMPACT
University of Cambridge - 30.3
University of Oxford - 26.8
University of Dundee - 26.5
Institute of Cancer Research - 23.9
University of Sheffield - 22.3
For example, one of our clinical trials (ICON6) has been looking at whether using the anti-angiogenic drug,
Cediranib
, can improve treatment outcomes for patients with
platinum-sensitive recurrent ovarian cancer
In the future, this could lead to a
new treatment
for ovarian cancer…
Researchfish captures any
medical produc
ts and
interventions
that have resulted from CRUK-funded research
NOW THE RESULTS ARE IN...
Researchfish can also tell us what impact CRUK-funded research has on
policy and practice
We know that CRUK-funded research has contributed to the development of
BOADICEA
(Breast and Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm)
Evaluate the
outcomes

of our
funding
Monitor progress against our
strategy
See where
we get
most return
for our investment
A computer program that calculates the risks of
breast

and ovarian cancer
based on a woman’s family history
Used by more than 3300
healthcare professionals
in more than 60 countries worldwide
Recommended as
a
risk assessment tool

in UK NICE clinical guidelines published in 2013 (CG164)
Incorporated in guidelines of
several countries
for the management of familial breast cancer
“World’s first polygenic breast cancer risk model, and it remains the only one available to the global healthcare community”
A great example of
scientific innovation!
Insight into our
PORTFOLIO
It is crucial that we monitor the outcomes of CRUK-funded research in order to meet the aims of the charity
Insight into our
RESEARCHERS
Insight into our
IMPACT
Patients received Cediranib + chemotherapy, followed by maintenance therapy
Significant improvement in progression free and overall survival
Results are now being prepared for consideration of submission to the European Medicines Agency for licensing
BOADICEA
is now...
What else?
For more information on Researchfish, contact the CRUK Researchfish Support Team on research.fish@cancer.org.uk
publications in high
impact journals (JIF band A+B)
419
In 2014, CRUK used Researchfish for the first time...
Researchfish provides us with a comprehensive view across our research portfolio
We can see the average number of outputs per award at different higher institutions*
*where number of awards is greater than 1% of Researchfish portfolio; excluding CRUK Institutes
Outputs from CRUK core-funded Institutes can also be evaluated
Institute Group Leaders have reported
Evaluate the
outcomes
of CRUK-funded research
So we can see how Researchfish helps us to…
Monitor progress towards CRUK's
strategic aims
What else?
Researchfish allows us to demonstrate that we are funding the leaders in cancer research
Innovative
AND
Engaging
!
Researchfish helps us to understand how CRUK-funded research leads to patient benefit over the longer term
Using Researchfish we can capture these important outputs of CRUK-funded research and follow progress over time
The information collected through Researchfish provides...
The next CRUK Researchfish submission period is
February – March 2016
We look forward to collecting more information on the outputs, outcomes and impact of CRUK-funded research
pause
Full transcript